{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hyperthyroidism&page=4", "query": { "condition": "Hyperthyroidism", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 95, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hyperthyroidism&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hyperthyroidism&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T19:15:52.848Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07369063", "title": "Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graves Disease", "Graves' Disease", "Hyperthyroidism" ], "interventions": [ { "name": "Ergocalciferol 50,000 IU", "type": "DRUG" }, { "name": "Methimazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "9 Years to 17 Years" }, "enrollment_count": 30, "start_date": "2025-08-01", "completion_date": "2027-02-28", "has_results": false, "last_update_posted_date": "2026-01-27", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "New Hyde Park, New York", "locations": [ { "city": "New Hyde Park", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07369063" }, { "nct_id": "NCT05635266", "title": "Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age-Related Macular Degeneration", "Allergies", "Alpha-Gal Syndrome", "Alzheimer Disease", "Amyloidosis", "Ankylosing Spondylitis", "Arthritis", "Alopecia Areata", "Asthma", "Atopic Dermatitis", "Autism", "Autoimmune Hepatitis", "Behcet's Disease", "Beta-Thalassemia", "Cancer", "Celiac Disease", "Kidney Diseases", "COPD", "Crohn Disease", "Cystic Fibrosis", "Diabetes", "Dravet Syndrome", "DMD", "Fibromyalgia", "Graves Disease", "Thyroid Diseases", "Hepatitis", "Hidradenitis Suppurativa", "ITP", "Leukemia", "ALS", "Lupus or SLE", "Lymphoma", "Multiple Sclerosis", "Myasthenia Gravis", "Heart Diseases", "Parkinson Disease", "Pemphigus Vulgaris", "Cirrhosis", "Psoriasis", "Schizophrenia", "Scleroderma", "Sickle Cell Disease", "Stroke", "Ulcerative Colitis", "Vasculitis", "Vitiligo" ], "interventions": [ { "name": "Specimen sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20000, "start_date": "2021-10-26", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05635266" }, { "nct_id": "NCT04311606", "title": "Anti-VEGF Therapy for Acute Thyroid Eye Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Thyroid Eye Disease" ], "interventions": [ { "name": "Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept", "type": "DRUG" }, { "name": "Sub-tenon injection of hyaluronidase (HA) followed by a sub-tenon injection of aflibercept", "type": "DRUG" }, { "name": "Sub-tenon injection of hyaluronidase (HA) alone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts Eye and Ear Infirmary", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2020-11-02", "completion_date": "2024-12-17", "has_results": true, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04311606" }, { "nct_id": "NCT01927406", "title": "The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Thyroid Eye Disease", "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "Prostaglandin Analog", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2014-06", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2018-05-15", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01927406" }, { "nct_id": "NCT06098755", "title": "The Sequestration of Holistic Stress Management Techniques for Adults", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress, Job", "PTSD", "Hypervigilance", "Hyperthyroidism", "Migraine", "Migraine With Aura", "Immunodeficiency", "Sickle Cell Trait", "Sickle Cell Disease", "Anemia, Sickle Cell", "Anemia", "Fatigue", "Anxiety", "Depression", "Flat Feet", "Lordosis", "TBI (Traumatic Brain Injury)", "Rheumatoid Arthritis", "Arthritis", "Masturbation", "Priapism", "Erectile Dysfunction", "Flight Reaction", "Hypertension", "Sexual Arousal Disorder", "Hemorrhoids", "Fibroid" ], "interventions": [ { "name": "Holistic Medicine (HM)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Goddess Zena I. Jones", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 0, "start_date": "2026-01-26", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Anchorage, Alaska", "locations": [ { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06098755" }, { "nct_id": "NCT00335062", "title": "TSH Receptor Antibody Heterogeneity in Children and Adolescents With Graves' Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Graves' Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "2 Years to 21 Years" }, "enrollment_count": 19, "start_date": "2005-08", "completion_date": "2010-02", "has_results": false, "last_update_posted_date": "2014-07-25", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00335062" }, { "nct_id": "NCT01950260", "title": "Early Levothyroxine Post Radioactive Iodine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Graves' Disease" ], "interventions": [ { "name": "Levothyroxine", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 61, "start_date": "2013-09", "completion_date": "2017-04", "has_results": true, "last_update_posted_date": "2019-10-29", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01950260" }, { "nct_id": "NCT03938545", "title": "ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graves' Ophthalmopathy (GO)" ], "interventions": [ { "name": "RVT-1401 (Administered via subcutaneous injection)", "type": "DRUG" }, { "name": "Placebo (Administered via subcutaneous injection)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Immunovant Sciences GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2019-07-23", "completion_date": "2021-04-15", "has_results": true, "last_update_posted_date": "2022-09-22", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 12, "location_summary": "Beverly Hills, California • Pasadena, California • Miami, Florida + 9 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03938545" }, { "nct_id": "NCT00595335", "title": "Trial of Rituximab for Graves' Ophthalmopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Thyroid-associated Ophthalmopathy" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rebecca Bahn", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 25, "start_date": "2008-04", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2016-01-01", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00595335" }, { "nct_id": "NCT06868459", "title": "Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hyperthyroidism; Goiter", "Multinodular Goiter", "Thyroid Nodules", "Thyroid Disease", "Hyperthyroidism", "Toxic Multinodular Goiter" ], "interventions": [ { "name": "Data Collection", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Sarasota Memorial Health Care System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 100, "start_date": "2025-04-01", "completion_date": "2028-04-01", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-20T19:15:52.848Z", "location_count": 4, "location_summary": "Jacksonville, Florida • Sarasota, Florida • Atlanta, Georgia + 1 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06868459" } ] }